Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-008919
Filing Date
2021-08-13
Accepted
2021-08-13 16:17:49
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cvm_10q.htm   iXBRL 10-Q 1008659
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cvm_ex31.htm EX-31 18176
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cvm_ex32.htm EX-32 3733
  Complete submission text file 0001654954-21-008919.txt   5288191

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cvm-20210630.xsd EX-101.SCH 59688
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20210630_cal.xml EX-101.CAL 44074
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20210630_def.xml EX-101.DEF 136523
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20210630_lab.xml EX-101.LAB 311538
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20210630_pre.xml EX-101.PRE 256065
9 EXTRACTED XBRL INSTANCE DOCUMENT cvm_10q_htm.xml XML 1038742
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-11889 | Film No.: 211172387
SIC: 2836 Biological Products, (No Diagnostic Substances)